Tremfya on BlueRx Essential (S1030-006)
guselkumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 12 per 180 days.
$3,760.72
Patient pays / month, after deductible
$4,221.97
Patient pays / month, before the $615.00 deductible
$11,282.15
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
TREMFYA 200 mg/2mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $15,042.86 for a month. Other covered strengths are listed below.
Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| TREMFYA 100 mg/mL Injection | 5 | $7,072.69 | PA · 3 per 56 days |
| TREMFYA 100 mg/mL Injection | 5 | $7,041.82 | PA · 3 per 56 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,764.16 | PA · 2 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,760.72 | PA · 12 per 180 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,763.73 | PA · 2 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)327-3998. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s1030-006